Veterinary Active Pharmaceutical Ingredients(API) Manufacturing Market $14.63 Billion By 2032,CAGR: 7.2%

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Worth USD 14.63 Billion By 2032 | CAGR: 7.2%

The global Veterinary Active Pharmaceutical Ingredients Manufacturing market size is expected to reach USD 14.63 Billion by 2032, according to a new study by Polaris Market Research. The report “Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Service Type (In House, Contract Outsourcing); By Synthesis Type; By Animal Type; By Therapeutic Category; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Veterinary active pharmaceutical ingredients (APIs) are essential components of animal medicines. These ingredients are responsible for producing the desired therapeutic effects and undergo rigorous testing and research before they are approved for commercial use. As the demand for animal healthcare solutions continues to increase, the market for high-quality veterinary APIs is also growing rapidly. The market is anticipated to grow owing to numerous factors such as research & development of veterinary products, increasing investment in outsourcing, facility expansion, and expenditure on animal health.

The veterinary active pharmaceutical ingredient (API) market has been driven by the operational and cost-effectiveness benefits of outsourcing the manufacturing of APIs. Animal health companies are actively seeking ways to optimize their operations and reduce costs. By outsourcing the production of veterinary APIs to specialized manufacturers, pharmaceutical companies can focus on their core strengths, including research, development, marketing, and distribution. This trend has led to a significant expansion in the veterinary API market, driven by a growing awareness of the importance of animal health and welfare.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

The market for veterinary active pharmaceutical ingredients (APIs) is witnessing significant growth owing to the rising prevalence of transboundary and zoonotic diseases. These diseases pose a significant risk to both animal and human populations and can spread rapidly across borders, posing a threat to public health, global trade, and animal welfare. The use of veterinary APIs has become crucial in controlling and preventing the spread of these diseases. They play a pivotal role in treating diseased animals, developing effective treatment strategies, and reducing the severity of symptoms, which aids in the recovery of affected animals. The veterinary API manufacturing sector is highly diverse and caters to the varied health needs of different animal species. It comprises a broad spectrum of companies ranging from large multinational pharmaceutical corporations to mid-sized enterprises.

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights

  • The market is dominated by the in-house segment, mainly due to the presence of numerous leading animal health companies that have set up their own API manufacturing facilities. This strategic move has helped them ensure an uninterrupted supply chain and maintain strict control over the quality of their products.
  • The veterinary API manufacturing market is projected to witness substantial growth in the biological API segment in the assessment period. This growth can be attributed to the rising need for advanced biologics and vaccines for animal healthcare.
  • In 2023, the global market for manufacturing veterinary active pharmaceutical ingredients (API) had the anti-infective segment as the largest contributor. This was due to the significant demand for antibiotics and other anti-microbial agents to treat bacterial, fungal, and viral infections in animals.
  • The global market in 2023 was dominated by the North American region, primarily due to the well-established animal healthcare industries in countries such as the United States and Canada. The presence of these industries has resulted in a high demand for veterinary APIs, making North America the largest market for veterinary APIs.
  • The global key market players include Alivira Animal Health Ltd., Chempro Pharma Pvt. Ltd., Elanco, Excel Industries Ltd., MENADIONA, Ofichem Group, Qilu Animal Health Products Co., Ltd., Siflon Drugs, SUANFARMA, Vetpharma, Zoetis, and among others.

Polaris Market Research has segmented the Veterinary Active Pharmaceutical Ingredients Manufacturing market report based on service type, synthesis type, animal type, therapeutic category, and region:

Veterinary Active Pharmaceutical Ingredients Manufacturing, Service Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • In House
  • Contract Outsourcing
  • Contract Development
    • Preclinical Development
    • Clinical Development
  • Contract Manufacturing

Veterinary Active Pharmaceutical Ingredients Manufacturing, Synthesis Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Biological API
  • Chemical-based API

Veterinary Active Pharmaceutical Ingredients Manufacturing, Animal Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Production Animals
  • Companion Animals

Veterinary Active Pharmaceutical Ingredients Manufacturing, Therapeutic Category Outlook (Revenue - USD Billion, 2019 - 2032)

  • Antiparasitic
  • Anti-infectives
  • NSAIDs
  • Others

Veterinary Active Pharmaceutical Ingredients Manufacturing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Scope

Report Attributes


Market size value in 2023

USD 7.86 billion

Revenue forecast in 2032

USD 14.63 billion


7.2% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2032

Segments covered

By Service Type, By Synthesis Type, By Animal Type, By Therapeutic Category, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa


Report customization as per your requirements with respect to countries, region and segmentation.

For Specific Research Requirements

Request for Customized Report

License and Pricing

Purchase Report Sections

  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Request for Discount Pricing